sample

BACKGROUND:Since 2004, a regimen of 6 months of treatment with oxaliplatin plus a fluoropyrimidine has been standard...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : New England Journal of Medicine

sample

ABSTRACTPurpose Reduction of adjuvant treatment duration may decrease toxicities without loss of efficacy in stage III...

Posté par : Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN
Nom de la revue : Journal of Clinical Oncology

sample

BACKGROUND:RAS mutations are currently sought for in tumor samples, which takes a median of almost 3 weeks in western...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Nom de la revue : Ann Oncol

sample

BACKGROUND:Expression of SRY [sex-determining region Y]-box11 (SOX11) is specific to mantle cell lymphoma (MCL) and...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : Exp Hematol Oncol

sample

ABSTRACTBackground and objective: Health-related quality of life (HRQoL) has become one relevant and...

Posté par : Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : Computer Methods and Programs in Biomedicine

sample

With advances in breast cancer (BC) gene panel testing, risk counseling has become increasingly complex, potentially...

Posté par : Dr. Amélie ANOTA
Nom de la revue : International Journal of Environmental Research and Public Health

sample

PurposeThe aim of this study was to determine the prevalence of adherence to adjuvant hormonal therapy (AHT) and to...

Posté par : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY, Dr. Amélie ANOTA
Nom de la revue : Breast Cancer Research and Treatment

sample

BackgroundPatients treated with chemotherapy for microsatellite unstable (MSI) and/or mismatch repair deficient (dMMR)...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : Eur J Cancer

sample

AbstractBACKGROUND:Current prognostic systems for myelodysplastic syndromes (MDS) are based on clinical, pathologic, and...

Posté par : Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : Cancer

sample

AbstractBackgroundWe studied the relationship between intermediate criteria and overall survival (OS) in metastatic...

Posté par : Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN
Nom de la revue : Clinical Colorectal Cancer

sample

Advances in cancer care delivery require revision and further development of questionnaires assessing patients’...

Posté par : Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : European Journal of Cancer Care

sample

AbstractBackground: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single...

Posté par : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Nom de la revue : Breast Cancer Research

sample

AbstractBackground The overexpression of human epidermal growth factor receptor-2 (HER2) in breast cancer is a poor...

Posté par : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY
Nom de la revue : BMC Cancer

sample

We conducted a retrospective study to assess the follow-up of patients with localized breast cancer and the first...

Posté par : Mme. Aurélia MEURISSE,
Nom de la revue : Breast

sample

Abstract Aim: Adjuvant clinical trials in early human epidermal growth factor receptor 2 (HER2)-positive breast cancer...

Posté par : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Nom de la revue : European Journal of Cancer

sample

Background: In advanced pancreatic ductal adenocarcinoma (aPDAC), there is no consensual strategy for...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Nom de la revue : JNCI J Natl Cancer Inst

sample

Since the MOSAIC study, oxaliplatin-based adjuvant chemotherapy has been the standard treatment of stage III colon...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : Annals of Oncology

sample

AbstractTraditionally, the efficacy of cancer treatment in patients with advance or metastatic disease in clinical...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : Annals of Oncology

sample

ABSTRACTIntroduction: Intermediate endpoints are often used as primary endpoints instead of overall survival (OS) in...

Posté par : , Pr. Franck BONNETAIN
Nom de la revue : Expert Review of Anticancer Therapy

sample

Background:To assess the efficacy of a patient educational program built according to guidelines that aims at reducing...

Posté par : Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Nom de la revue : British Journal of Cancer

2015-2018 © Copyright - UMQVC.org

Website by Pearlweb